Gilead Sciences

American biopharmaceutical company

Commentary Governance Corporate Governance, Shareholder Capitalism, Proxy Monitor
May 19 2022
Proxy Monitor 2022 Voting Results: Mid-Season Review
By James R. Copland Read time 14 mins Read More
Commentary Health
Jan 30 2021
Our Leaders Failed Us on COVID, but Miracle Science Brings Hope for Relief
By Joel Zinberg Read time 5 mins Read More
Commentary Governance Corporate Governance, Shareholder Capitalism, Proxy Monitor
May 19 2020
Proxy Monitor 2020: Voting Results are In: Duke Energy, Pepsi, Verizon, and More
By James R. Copland Read time 7 mins Read More
Commentary Governance Corporate Governance, Shareholder Capitalism, Proxy Monitor
Jun 21 2019
Proxy Monitor 2019: Voting Results for Amex, Home Depot, and More
By James R. Copland Read time 5 mins Read More
Commentary Health Pharmaceuticals
Jan 17 2019
There’s a Better Way to Achieve Drug-Pricing Reform
By Tim Rice Read time 4 mins Read More
Commentary Economics Healthcare
Nov 13 2018
The Trump Administration’s Foolish Plan to Lower Drug Prices
By Tim Rice Read time 6 mins Read More
Commentary Health, Health Pharmaceuticals, FDA Reform, Pharmaceuticals
May 04 2018
Want Companies to Innovate Life-Saving Drugs? Don’t Dissuade Them With Price Controls.
By Tim Rice Read time 5 mins Read More
Commentary Health, Health Healthcare, Pharmaceuticals
Feb 10 2016
Want to Eradicate Hep C? Fix Medicaid's Cash Flow Problem
By Paul Howard Read time 4 mins Read More
Commentary Health, Health Pharmaceuticals, FDA Reform, Pharmaceuticals
Sep 09 2015
Why I'm Not Worried About Drug Prices How I Stopped Worrying And Learned To Love The $100,000 Drug
By Yevgeniy Feyman Read time 6 mins Read More
Commentary Health, Health, Health Pharmaceuticals, FDA Reform, Pharmaceuticals
Feb 09 2015
Innovation And Its Discontents: FDA Regulation, Competition, And Drug Pricing
By Paul Howard Read time 5 mins Read More